1,549
Views
48
CrossRef citations to date
0
Altmetric
Labeling and Safety

Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi

, PhD, , BA, , PhD, , PhD & , PhD

References

  • Armenian P, Darracq M, Gevorkyan J, Clark S, Kaye B, Brandehoff NP. 2018. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: a case series and review of the literature. Neuropharmacology. 134(Pt A):82–91. doi:10.1016/j.neuropharm.2017.10.017.
  • Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. 2017. Labeling accuracy of cannabidiol extracts sold online. JAMA. 318(17):1708–1709. doi:10.1001/jama.2017.11909.
  • Cherian SV, Kumar A, Estrada-Y-Martin RM. 2020. E-cigarette or vaping product-associated lung injury: a review. Am J Med. doi:10.1016/j.amjmed.2020.02.004..
  • Conuel EJ, Chieng HC, Fantauzzi J, Pokhrek K, Goldman C, Smith TC, Tiwari A, Chopra A, Judson MA. 2019. Cannabinoid oil vaping-associated lung injury and its radiographic appearance. Am J Med. doi:10.1016/j.amjmed.2019.10.032..
  • Corroon J, Kight R. 2018. Regulatory status of cannabidiol in the United States: a perspective. Cannabis Cannabinoid Res. 3(1):190–194. doi:10.1089/can.2018.0030.
  • Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E, Molina-Holgado F. 2017. Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events. Adv Pharmacol. 80:135–168. doi:10.1016/bs.apha.2017.05.001.
  • ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. 2017. Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod. 103:1–36. doi:10.1007/978-3-319-45541-9_1.
  • ElSohly MA, Slade D. 2005. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78(5):539–548. doi:10.1016/j.lfs.2005.09.011.
  • Fryman C, Lou B, Weber AG, Steinberg HN, Khanijo S, Iakovou A, Makaryus MR. 2020. Acute respiratory failure associated with vaping. Chest. 157(3):e63–e68. doi:10.1016/j.chest.2019.10.057.
  • Glisson JK, Walker LA. 2010. How physicians should evaluate dietary supplements. Am J Med. 123(7):577–582. doi:10.1016/j.amjmed.2009.10.017.
  • Gurley BJ, Gardner SF, Hubbard MA. 2000. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 57(10):963–969. doi:10.1093/ajhp/57.10.963.
  • Heinzerling A, Armatas C, Karmarkar E, Attfield K, Guo W, Wang Y, Vrdoljak G, Moezzi B, Xu D, Wagner J, et al. 2020. Severe lung injury associated with use of e-cigarette, or vaping products – California. JAMA Intern Med. doi:10.1001/jamainternmed.2020.0664..
  • H.R.2 – Agriculture Improvement Act of 2018. Public Law No: 115-334. Dec. 20, 2018.
  • Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardo FP. 2019. Cannabidiol adverse effects and toxicity. Curr Neuropharmacol. 17(10):974–989. doi:10.2174/1570159X17666190603171901.
  • Ibrahim EA, Gul W, Gul SW, Stamper BJ, Hadad GM, Salam RAA, Ibrahim AK, Ahmed SA, Chandra S, Lata H, et al. 2018. Determination of acid and neutral cannabinoids in extracts of different strains of Cannabis sativa using GC-FID. Planta Med. 84(04):250–259. doi:10.1055/s-0043-124088.
  • Liebling JP, Clarkson NJ, Gibbs BW, Yates AS, O’Sullivan SE. 2020. An analysis if over-the-counter cannabidiol products in the United Kingdom. Cannabis Cannabinoid Res. doi:10.1089/can.2019.0078.
  • Pacher P, Steffens S, Haskó G, Schindler TH, Kunos G. 2018. Cardiovascular effecs of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 15(3):151–166. doi:10.1038/nrcardio.2017.130.
  • Pauli CS, Conroy M, Vanden Heuvel BD, Park S-H. 2020. Cannabidiol drugs clinical trial outcomes and adverse effects. Front Pharmacol. 11:63. doi:10.3389/fphar.2020.00063.
  • Pintori N, Loi B, Mereu M. 2017. Synthetic cannabinoids: the hidden side of Spice drugs. Behav Pharmacol. 28(6):409–419. doi:10.1097/FBP.0000000000000323.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.